Apples and oranges? Can second-generation vaccines become as low cost as generic medicines?

Aurelia Nguyen, Nina Schwalbe

Vaccine 2019

A step change in cost will require fundamental shifts in vaccine technologies and how they are developed, regulated and even manufactured.